We have located links that may give you full text access.
Lattice Boltzmann modeling of self-propelled Leidenfrost droplets on ratchet surfaces.
Soft Matter 2016 January 8
In this paper, the self-propelled motion of Leidenfrost droplets on ratchet surfaces is numerically investigated using a thermal multiphase lattice Boltzmann model with liquid-vapor phase change. The capability of the model for simulating evaporation is validated via the D(2) law. Using the model, we first study the performances of Leidenfrost droplets on horizontal ratchet surfaces. It is numerically shown that the motion of self-propelled Leidenfrost droplets on ratchet surfaces is owing to the asymmetry of the ratchets and the vapor flows beneath the droplets. It is found that the Leidenfrost droplets move in the direction toward the slowly inclined side from the ratchet peaks, which agrees with the direction of droplet motion in experiments [Linke et al., Phys. Rev. Lett., 2006, 96, 154502]. Moreover, the influences of the ratchet aspect ratio are investigated. For the considered ratchet surfaces, a critical value of the ratchet aspect ratio is approximately found, which corresponds to the maximum droplet moving velocity. Furthermore, the processes that the Leidenfrost droplets climb uphill on inclined ratchet surfaces are also studied. Numerical results show that the maximum inclination angle at which a Leidenfrost droplet can still climb uphill successfully is affected by the initial radius of the droplet.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app